Payment overview · 2025
General Payments
$17.30
1 reported records · 1 companies
Healthcare provider profile · identity verified
Jeffrey L White, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · PLATTEVILLE, WI · NPI 1093761785
Verified facts
What the public records show
CMS Open Payments records show Jeffrey L White, D.O. received $17.30 in general payments during 2025 across 1 reported records.
Alkermes, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Alkermes, Inc. | Unresolved — no canonical attribution shown | $17.30 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $17.30 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ARISTADA Normalized: aristada |
Drug | Alkermes, Inc. | $17.30 | 1 | 2025 |
Source payment records
|
|||||
| LYBALVI Normalized: lybalvi |
Drug | Alkermes, Inc. | $17.30 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 728 | 174 |
| Amlodipine Besylate | Amlodipine Besylate | 600 | 150 |
| Omeprazole | Omeprazole | 563 | 147 |
| Furosemide | Furosemide | 526 | 92 |
| Losartan Potassium | Losartan Potassium | 525 | 121 |
| Levothyroxine Sodium | Levothyroxine Sodium | 420 | 83 |
| Eliquis | Apixaban | 383 | 44 |
| Potassium Chloride | Potassium Chloride | 343 | 65 |
| Metoprolol Tartrate | Metoprolol Tartrate | 296 | 69 |
| Tamsulosin Hcl | Tamsulosin Hcl | 256 | 64 |
| Simvastatin | Simvastatin | 254 | 67 |
| Metoprolol Succinate | Metoprolol Succinate | 248 | 60 |
| Mirtazapine | Mirtazapine | 233 | 42 |
| Metformin Hcl | Metformin Hcl | 232 | 58 |
| Duloxetine Hcl | Duloxetine Hcl | 226 | 39 |
| Escitalopram Oxalate | Escitalopram Oxalate | 218 | 40 |
| Pantoprazole Sodium | Pantoprazole Sodium | 213 | 50 |
| Hydrochlorothiazide | Hydrochlorothiazide | 212 | 56 |
| Gabapentin | Gabapentin | 194 | 42 |
| Allopurinol | Allopurinol | 190 | 42 |
| Warfarin Sodium | Warfarin Sodium | 182 | 24 |
| Sertraline Hcl | Sertraline Hcl | 176 | 37 |
| Lisinopril | Lisinopril | 174 | 44 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 166 | 41 |
| Xarelto | Rivaroxaban | 163 | 19 |
| Trazodone Hcl | Trazodone Hcl | 146 | 33 |
| Spironolactone | Spironolactone | 137 | 28 |
| Tramadol Hcl | Tramadol Hcl | 125 | 37 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 119 | 32 |
| Pravastatin Sodium | Pravastatin Sodium | 115 | 31 |
| Clopidogrel | Clopidogrel Bisulfate | 114 | 21 |
| Carvedilol | Carvedilol | 112 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 101 | 33 |
| Alendronate Sodium | Alendronate Sodium | 98 | 20 |
| Donepezil Hcl | Donepezil Hcl | 95 | 21 |
| Prednisone | Prednisone | 95 | 35 |
| Lorazepam | Lorazepam | 93 | 42 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 92 | 24 |
| Finasteride | Finasteride | 91 | 22 |
| Quetiapine Fumarate | Quetiapine Fumarate | 91 | 12 |
| Methylprednisolone | Methylprednisolone | 88 | 70 |
| Ozempic | Semaglutide | 88 | 16 |
| Atenolol | Atenolol | 87 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 87 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 85 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 83 | 23 |
| Cephalexin | Cephalexin | 80 | 55 |
| Glimepiride | Glimepiride | 78 | 22 |
| Oxybutynin Chloride | Oxybutynin Chloride | 78 | 22 |
| Fluoxetine Hcl | Fluoxetine Hcl | 70 | 16 |
| Celecoxib | Celecoxib | 67 | 24 |
| Alprazolam | Alprazolam | 66 | 18 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 66 | 19 |
| Memantine Hcl | Memantine Hcl | 65 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 64 | 13 |
| Famotidine | Famotidine | 58 | 11 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 54 | 54 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 53 | suppressed |
| Chlorthalidone | Chlorthalidone | 50 | 11 |
| Breo Ellipta | Fluticasone/Vilanterol | 49 | suppressed |
| Clonazepam | Clonazepam | 49 | suppressed |
| Latanoprost | Latanoprost | 49 | suppressed |
| Azithromycin | Azithromycin | 47 | 40 |
| Bupropion Hcl | Bupropion Hcl | 46 | 15 |
| Metformin Hcl Er | Metformin Hcl | 45 | 11 |
| Cholestyramine | Cholestyramine (With Sugar) | 43 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 43 | 13 |
| Levetiracetam | Levetiracetam | 43 | suppressed |
| Valsartan | Valsartan | 43 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 42 | suppressed |
| Lovastatin | Lovastatin | 42 | 11 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 42 | 30 |
| Fenofibrate | Fenofibrate | 41 | 13 |
| Nitroglycerin | Nitroglycerin | 41 | 18 |
| Paroxetine Hcl | Paroxetine Hcl | 41 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 40 | 21 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 38 | 38 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 37 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 37 | 25 |
| Diazepam | Diazepam | 36 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 36 | 13 |
| Dicloxacillin Sodium | Dicloxacillin Sodium | 35 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 35 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 34 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 34 | suppressed |
| Myrbetriq | Mirabegron | 34 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 34 | 25 |
| Diltiazem 24hr Er | Diltiazem Hcl | 33 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 33 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 32 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 32 | suppressed |
| Nystatin | Nystatin | 32 | 22 |
| Benazepril Hcl | Benazepril Hcl | 31 | suppressed |
| Sucralfate | Sucralfate | 31 | suppressed |
| Topiramate | Topiramate | 31 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 30 | suppressed |
| Novolog Flexpen | Insulin Aspart | 30 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 29 | suppressed |
| Aripiprazole | Aripiprazole | 28 | suppressed |
| Cefdinir | Cefdinir | 28 | 24 |
| Amoxicillin | Amoxicillin | 27 | 13 |
| Acyclovir | Acyclovir | 26 | suppressed |
| Tradjenta | Linagliptin | 26 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 25 | 24 |
| Bupropion Xl | Bupropion Hcl | 25 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 25 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 25 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 25 | suppressed |
| Bumetanide | Bumetanide | 24 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 24 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 24 | suppressed |
| Trulicity | Dulaglutide | 24 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 24 | suppressed |
| Gemfibrozil | Gemfibrozil | 23 | suppressed |
| Metolazone | Metolazone | 23 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 22 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 22 | suppressed |
| Fentanyl | Fentanyl | 22 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 22 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 22 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 20 | 20 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 20 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Jardiance | Empagliflozin | 19 | suppressed |
| Mounjaro | Tirzepatide | 19 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 18 | suppressed |
| Carbamazepine | Carbamazepine | 18 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 18 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 18 | suppressed |
| Timolol Maleate | Timolol Maleate | 18 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 18 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 17 | 12 |
| Ezetimibe | Ezetimibe | 17 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 17 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 17 | 11 |
| Primidone | Primidone | 17 | suppressed |
| Baclofen | Baclofen | 16 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Hydrocortisone | Hydrocortisone | 16 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 15 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 15 | suppressed |
| Lansoprazole | Lansoprazole | 15 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 14 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 14 | suppressed |
| Dulera | Mometasone/Formoterol | 14 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 14 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 14 | suppressed |
| Temazepam | Temazepam | 14 | suppressed |
| Estradiol | Estradiol | 13 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Itraconazole | Itraconazole | 13 | suppressed |
| Januvia | Sitagliptin Phosphate | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Cholestyramine Light | Cholestyramine | 12 | suppressed |
| Copaxone | Glatiramer Acetate | 12 | suppressed |
| Digoxin | Digoxin | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Gemtesa | Vibegron | 12 | suppressed |
| Niacin Er | Niacin | 12 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Trimethoprim | Trimethoprim | 12 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 11 | suppressed |
| Glipizide | Glipizide | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Nifedipine Er | Nifedipine | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 11 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $17.30 · 1 records | Alkermes, Inc. | ARISTADA, LYBALVI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error